Our transcriptomic analysis identified upregulated expression of MHC class I, which present tumor antigens to CD8+ T cells and mediate CD8+ T cell-dependent antitumor effects [21], in Cases 3, 4, and 10. This evidence concerns the gene CD8A and neoplasm.